The latest GID BIO and cellular therapy news.
OrthoCarolina joins as trial site in pivotal trial
OrthoCarolina, GID BIO’s newest trial site, is led by Dr. Claude T. Moorman III as principal investigator. Dr. Moorman is a sports medicine surgeon at OrthoCarolina's Sports Medicine Center; the president of Atrium Health's Musculoskeletal Institute; and Chair of Atrium Health's Department of Orthopaedic Surgery...
Wake Forest Medical School added as newest site in pivotal trial
Neil Sparks, DO, MS, a North Carolina physician specializing in the comprehensive primary and musculoskeletal care of children, adults and families, is the newest principal investigator in GID BIO's pivotal trial...
Orlando Medical News features GID BIO’s cellular therapy and pivotal clinical trial
San Antonio Business Journal features GID BIO’s cellular therapy and pivotal clinical trial principal investigator, Dr. Jaime Garza: “On the forefront of new cell therapy research, an Alamo City surgeon has a key role in moving new medical technology to market”
Late-stage biotech GID BIO wins funding from Richard King Mellon Foundation
LOUISVILLE, Colo. and PITTSBURGH, Aug. 18, 2020 -- Following FDA clearance of an expanded access protocol to treat a small group of COVID-19 patients using the GID BIO technology platform, The Richard King Mellon Foundation has awarded $250,000 to GID BIO to conduct the study for patients with severe respiratory distress due to COVID-19...